Power Morcellator Lawsuit | Morcellation Cancer Lawsuits
Power Morcellator Lawsuit, Morcellation Lawsuit, Power Morcellator Cancer Lawsuit | Uterine Cancer, Leiomyosarcoma, Uterine Sarcoma
Morcellators, electronic devices used to remove tissue during hysterectomies and other gynecological surgeries, have been tied to the spread of a rare, but aggressive, uterine cancer called leiomyosarcoma. Since 2013, a number of power morcellator lawsuits have been filed against Ethicon Inc., Blue Endo, Lina Medical, and other power morcellator medical device manufacturers that market these instruments. Plaintiffs in these power morcellator lawsuits claim that they were never warned that morcellation has the potential to “seed” undiagnosed leiomyosarcoma cancer that may be present in uterine fibroids, leading to the spread of this rare cancer.
Power Morcellator Lawsuit Information
A dedicated leader in medical injury litigation, Southern Med Law has successfully taken on some of the largest medical companies on behalf of their clients. If you or someone you love had a hysterectomy with power morcellation, and developed uterine cancer or leiomyosarcoma, contact Southern Med Law to inquire about filing a power morcellator lawsuit. Southern Med Law offers free power morcellator lawsuit legal consultations to those who have developed leiomyosarcoma cancer due to power morcellation . Call 1-205-547-5525 or fill out our online form located on the www.southernmedlaw.com website.
Power Morcellation and Leiomyosarcoma
It is estimated that morcellation is used in some 80,000 of the 600,000 hysterectomies performed annually, most for the treatment of benign tumors called fibroids. The power morcellator is used during laparoscopic surgeries to grind down the fibroids, so that smaller pieces of tissue can be removed through small incisions. On rare occasions, cancer cells from undiagnosed leiomyosarcoma can hide within these fibroids.
Leiomyosarcoma Cancer
Leiomyosarcoma is a cancer of smooth muscle cells that can occur in the uterus, stomach and intestines, walls of all blood vessels, and skin. While this cancer is very rare, there is no reliable test to diagnose potential malignancy in fibroids before a woman undergoes morcellation. If the cancer is present during morcellation, the cells can be spread throughout the body, quickly changing a stage 1 cancer into stage 4.
In December 2013, four Boston-area doctors submitted a draft paper to the New England Journal of Medicine calling for a moratorium on power morcellation, asserting that a much higher number of women than previously thought have undetected cancer in their fibroids. The team reviewed 10 studies of 30,000 women who had undergone morcellation, and found that nearly 1 in 400 women were found to have uterine sarcoma in the removed tissue.
In November 2012, a study published by doctors at Brigham and Women’s Hospital looked at nearly 1,100 power morcellations performed at the facility, and found the rate of sarcoma was 1 in 546. They concluded that the rate of the far-deadlier leiomyosarcoma was nearly 1 in 1,000. According to the authors of the study, the occurrence of leiomyosarcoma was “much higher than the empiric rate of 1-in-10,000 typically quoted to patients during their pre-procedure briefing.”
Some hospitals have taken action to mitigate the risk that women will develop this dangerous cancer after morcellation. In December 2013, Brigham and Women’s Hospital said it would impose new limits on the procedure. Massachusetts General Hospital also decided to change what it tells women about the risks associated with the procedure.
Free Legal Consultations by Southern Med Law And Filing A Power Morcellator Lawsuit
The head of Southern Med Law, Dr. François Blaudeau is a board certified obstetrician / gynecologist, as well as a practicing attorney and Southern Med Law was one of the first to file a power morcellation lawsuit in U.S. District Court, Eastern District of New York (6:14-cv-06218), on behalf of New York residents Brenda Leuzzi and her husband which alleges that she developed cancer after undergoing a hysterectomy. Southern Med Law and Dr. François Blaudeau possess a unique understanding of the medical and legal questions at issue in power morcellator cancer lawsuit claims. It is this in-depth knowledge that is tantamount to a successful legal representation that protects the rights of the injured. The staff at Southern Med Law is not only trained in successfully handling your legal needs but also understand the pain and suffering and treatment from a medical point of view, and is committed to protecting the rights of all individuals. A dedicated leader in medical injury litigation, Southern Med Law has successfully taken on some of the largest medical companies on behalf of their clients. If you or someone you love had a hysterectomy with power morcellation, and developed uterine cancer or leiomyosarcoma, contact Southern Med Law to inquire about filing a power morcellator lawsuit. Southern Med Law offers free power morcellator lawsuit legal consultations to those who have developed leiomyosarcoma cancer due to power morcellation . Call 1-205-547-5525 or fill out our online form located on the www.southernmedlaw.com website.
Other Power Morcellator Lawsuit News
Wall Street Journal – A Medical Device Is Sidelined, but Too Late for One Woman
Wall Street Journal – How Surgical Robots Spurred Morcellator Use
Wall Street Journal – Families Vent Pain and Anger Over Risky Uterine Procedure
WHEC Rochester – Local health system changing hysterectomy procedure for cancer patients
Democrat & Chronicle – Husband grieves over “unnecessary” death
Democrat & Chronicle – Perinton woman who underwent morcellation dies